About us

Members

Members

Key Executives
World’s leading scientific minds in clinical, science and big data research for brain diseases.
Nam-Gu Her, Ph.D.
CEO

Deep field knowledge in project management, business development and overall biotech operations

Experience & Education
  • Former Head of R&D, AimedBio Inc.
  • Principal investigator on 9+ grants (KDDF, KHIDI, NRF, MSS, SBA, NCC, CCRDP) 
  • Principal Scientist/Team Leader, Samsung Medical Center
  • Research Professor, School of Medicine, Sungkyunkwan University
  • Postdoctoral Associate, SBP Medical Discovery Institute, La Jolla, CA, USA
  • B.S., M.S., Ph.D., School of Life Sciences and Biotechnology, Korea University
Do-Hyun Nam, M.D., Ph.D.
Founder & Chairman, CTO

Renowned neurosurgeon at Samsung Medical Center with 32 years experience in brain tumor & CNS diseases

Experience & Education
  • M.D., Ph.D., Seoul National University College of Medicine
  • Professor, Department of Neurosurgery, Samsung Medical Center, Sungkyunkwan University School of Medicine
  • Professor, Department of Health Sciences & Technology, SAIHST, Sungkyunkwan University
  • Staff, Department of Neurosurgery, Samsung Medical Center
  • Director, Institute for Refractory Cancer Research, Samsung Medical Center
Byeongkwi Min, Ph.D.
Head of R&D / Director

Broad expertise relevant to antibody-based therapeutics

Experience & Education
  • Former Director of Antibody Engineering, AimedBio Inc.
  • Antibody Engineering Team, Samsung Medical Center
  • Ph.D., Sungkyunkwan University
  • Inventor of patents for antibody-based therapeutics and technology
Hyejin Kim, Ph.D.
Assay Development / Director

Molecular medicine expert supervising assay development for novel therapeutics

Experience & Education
  • Director of assay development, AimedBio Inc.
  • Principal investigator on grants (KDDF, NRF)
  • Principal Scientist, Samsung Medical Center
  • Research Professor, School of Medicine, Sungkyunkwan University
  • Postdoc, Seoul National University College of Medicine
  • PhD., Seoul National University College of Medicine
Taekyoung Kim
Management Division / Head Director

30 years experience in Management Division

Experience & Education
  • Vice President, Cheil General Hospital
  • Senior Manager, Managent Division, Bundang CHA Hospital
Board Members
Do-Hyun Nam, M.D., Ph.D.
Founder & Chairman, CTO

Renowned neurosurgeon at Samsung Medical Center with 32 years experience in brain tumor & CNS diseases

Experience & Education
  • M.D., Ph.D., Seoul National University College of Medicine
  • Professor, Department of Neurosurgery, Samsung Medical Center, Sungkyunkwan University School of Medicine
  • Professor, Department of Health Sciences & Technology, SAIHST, Sungkyunkwan University
  • Staff, Department of Neurosurgery, Samsung Medical Center
  • Director, Institute for Refractory Cancer Research, Samsung Medical Center
Wonjin Park, M.D., Ph.D.
Managing Director in New Strategic Business, AimedBio Experience & Education
  • M.D., Ph.D., Seoul National University College of Medicine
  • Chief Director, Global Healthcare of Seocho-gu, Seoul
  • Director, Wonjin Plastic Surgery Clinic
  • Plastic Surgeon, Seoul National University Hospital
  • Professor, Department of Plastic Surgery, Samsung Medical Center
Min-Chul Shin, KICPA
CEO, Sunmyung Accounting Firm Experience & Education
  • Masters (Business), Sungkyunkwan University
  • Advisor of Financial Services Bureau, Board of Audit and Inspection
  • Auditor General, Seoul Welfare Foundation
  • Member, Asset Management Committee, The Korea Institute for Advancement of Technology
Byeong-Geon Rhee
Chairman & CEO, GI Innovation, Inc. Experience & Education
  • Ph.D. (Chemical Engineering/Medical Engineering), Rice University
  • Chairman, Korea Support Committee for International Vaccine Institute
  • Non-executive director, Korea Health Industry Development Institute
  • Member, The National Academy of Engineering of Korea
  • President & CEO, GC Pharma
  • Former Chairman, Korea BIO
  • Former Chairman, Council for Advanced Regenerative Medicine
Advisory Board
Daniel D. Von Hoff, M.D.
Daniel D. Von Hoff, M.D.
Clinical Advisor

Physician in Chief, Distinguished Professor, TGEN
Sr. Consultant-Clinical Investigations, City of Hope
Professor of Medicine, Mayo Clinic

Roger Stupp, M.D.
Roger Stupp, M.D.
Clinical Advisor

Chief of Neuro-oncology, Northwestern Univ.
Assoc. Director, Strategic Initiatives, Robert H. Lurie
Comprehensive Cancer Center, Northwestern Univ.
President, European Organization for Research
and Treatment of Cancer

Ravi Chari, Ph.D.
Ravi Chari, Ph.D.
Scientific Advisor

Biotech Consultant, Rchari Consulting
Former VP, Chem&Bio, Immunogen Inc

Antonio Iavarone, M.D.
Antonio Iavarone, M.D.
Scientific Advisor

Deputy Director, Sylvester Comprehensive Cancer, Miller School of Medicine, University of Miami
Professor, Department of Neurology, Miller School of Medicine, University of Miami

Neil Gibson, Ph.D.
Neil Gibson, Ph.D.
Scientific Advisor

President and CEO, Adanate
President and CEO, PDI Therapeutics
CSO, Silarus Therapeutics
Sr. VP, COI Pharmaceuticals and Avalon
Venture Incubator

Roland Newman, Ph.D.
Roland Newman, Ph.D.
Business Advisor

Former CSO, Tanabe Research Laboratories
Former Principal, RANA Consulting
Former Sr. Director of Business Development,
Biogen-Idec

Ralph Lin, Ph.D.
Ralph Lin, Ph.D.
Business Advisor

Sr. Director and Head of Licensing, Arena
Pharmaceuticals
Former Sr. Director, Search & Evaluation and
Program Management, Ignyta Inc

Robert Wild, Ph.D.
Robert Wild, Ph.D.
Scientific Advisor

Founder & President, RC Wild BioPharma Consulting, LLC

Partnering Groups
To bring precision medicine to bedside, AIMEDBIO is currently partnering with the finest groups around the world.
tgenArizona, USA
CBmedAustria
astarSingapore
컬럼비아대학교New York, USA
서울대학교병원South Korea
건국대학교병원South Korea
삼성의료원South Korea
국립암센터South Korea
성균관대학교South Korea
Platform >>